Improved CGM Glucometrics and More Visits for Pediatric Type 1 Diabetes Using Telemedicine During 1 Year of COVID-19

The COVID-19 pandemic led to rapid adoption of telemedicine for the care of youth with type 1 diabetes (T1D). We assessed the utility of a primarily virtual care model by comparing glucometrics from a pediatric sample with T1D using continuous glucose monitoring (CGM) both before and during the pand...

Full description

Saved in:
Bibliographic Details
Published in:The journal of clinical endocrinology and metabolism 2022-09, Vol.107 (10), p.e4197-e4202
Main Authors: Kaushal, Tara, Tinsley, Liane J, Volkening, Lisa K, Turcotte, Christine, Laffel, Lori M
Format: Article
Language:English
Subjects:
Adolescent
Analysis
Blood Glucose
Blood Glucose Self-Monitoring
Blood sugar monitoring
Child
Child, Preschool
Children
COVID-19 - epidemiology
Dextrose
Diabetes Mellitus, Type 1 - epidemiology
Diabetes Mellitus, Type 1 - therapy
Diabetes therapy
Epidemics
Female
Glucose
Glycated Hemoglobin - analysis
Glycosylated hemoglobin
Health aspects
Humans
Infant
Male
Medical records
Online Only
Pandemics
Pediatrics
Telemedicine
Type 1 diabetes
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:The COVID-19 pandemic led to rapid adoption of telemedicine for the care of youth with type 1 diabetes (T1D). We assessed the utility of a primarily virtual care model by comparing glucometrics from a pediatric sample with T1D using continuous glucose monitoring (CGM) both before and during the pandemic. Pediatric patients aged 1 to 17 years with T1D duration ≥ 1 year if ≥ 6 years old or ≥ 6 months if 
ISSN:0021-972X
1945-7197
DOI:10.1210/clinem/dgac476